Strong long-term growth prospects as a global leader in precision care post-spin-off from GE
Revenue and margin growth drivers: innovation, business optimization, and organic investment
Spin completion expected after
Business Outlook
For the fourth quarter of 2022, the Company expects total net revenues to be between RMB3.15 billion to RMB3.25 billion, representing a decrease
Outlook
For fiscal 2022 ending on January 28, 2023, the Company raised its previously issued guidance. The Company now expects net sales in a range of $1.395 billion to $1.410 billion as
Fourth Quarter and Full-Year 2022 Outlook:
For the fourth quarter of fiscal year 2022, net sales are expected to be in the range of $370 million to $385 million, anticipating that same